ORGO - Organogenesis Holdings Inc A (Healthcare: Drug Manufacturers - Specialty & Generic) Projected Earnings Date: 2024-08-12    (Delayed quote data   2025-01-06)
Last
 3.12		 Change
 ⇑ +0.02   (+0.65%)		 Volume
  624,862
Open
 3.11		 High
 3.18		 Low
 3.09
8EMA (Daily)
 3.15		 40EMA (Daily)
 3.36		 50EMA (Daily)
 3.35		 STO (Daily)
 17.169		 MACD Hist (Daily)
 -0.045
8EMA (Weekly)
 3.257		 40EMA (Weekly)
 3.11		 50EMA (Weekly)
 3.11		 STO (Weekly)
 24.898		 MACD Hist (Weekly)
 -0.074
Company Profile
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical and sports medicine markets. Its product category includes Advanced Wound Care and Surgical and Sports Medicine. The company generates maximum revenue from Advanced Wound Care products. Some of its products include PuraPly Antimicrobial, Affinity, NuShield, Apligraf, Dermagraft and others.
optionchance optionchance
⇒ Home | Chart and Research | Education | About Us  

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Questions or Comments: support@optionchance.com
Copyright © 2025 OptionChance.com